Literature DB >> 11683624

Solution structure and backbone dynamics of the human DNA ligase IIIalpha BRCT domain.

V V Krishnan1, K H Thornton, M P Thelen, M Cosman.   

Abstract

BRCT (BRCA1 carboxyl terminus) domains are found in a number of DNA repair enzymes and cell cycle regulators and are believed to mediate important protein-protein interactions. The DNA ligase IIIalpha BRCT domain partners with the distal BRCT domain of the DNA repair protein XRCC1 (X1BRCTb) in the DNA base excision repair (BER) pathway. To elucidate the mechanisms by which these two domains can interact, we have determined the solution structure of human ligase IIIalpha BRCT (L3[86], residues 837-922). The structure of L3[86] consists of a beta2beta1beta3beta4 parallel sheet with a two-alpha-helix bundle packed against one face of the sheet. This fold is conserved in several proteins having a wide range of activities, including X1BRCTb [Zhang, X. D., et al. (1998) EMBO J. 17, 6404-6411]. L3[86] exists as a dimer in solution, but an insufficient number of NOE restraints precluded the determination of the homodimer structure. However, 13C isotope-filtered and hydrogen-deuterium exchange experiments indicate that the N-terminus, alpha1, the alpha1-beta2 loop, and the three residues following alpha2 are involved in forming the dimer interface, as similarly observed in the structure of X1BRCTb. NOE and dynamic data indicate that several residues (837-844) in the N-terminal region appear to interconvert between helix and random coil conformations. Further studies of other BRCT domains and of their complexes are needed to address how these proteins interact with one another, and to shed light on how mutations can lead to disruption of function and ultimately disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11683624     DOI: 10.1021/bi010979g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  Structural basis of BACH1 phosphopeptide recognition by BRCA1 tandem BRCT domains.

Authors:  Maria Victoria E Botuyan; Yves Nominé; Xiaochun Yu; Nenad Juranic; Slobodan Macura; Junjie Chen; Georges Mer
Journal:  Structure       Date:  2004-07       Impact factor: 5.006

2.  The α2 helix in the DNA ligase IV BRCT-1 domain is required for targeted degradation of ligase IV during adenovirus infection.

Authors:  Timra Gilson; Amy E Greer; Alessandro Vindigni; Gary Ketner; Leslyn A Hanakahi
Journal:  Virology       Date:  2012-04-24       Impact factor: 3.616

3.  Structure of the DNA-bound BRCA1 C-terminal region from human replication factor C p140 and model of the protein-DNA complex.

Authors:  Masakazu Kobayashi; Eiso Ab; Alexander M J J Bonvin; Gregg Siegal
Journal:  J Biol Chem       Date:  2010-01-15       Impact factor: 5.157

4.  Evidence for a structural relationship between BRCT domains and the helicase domains of the replication initiators encoded by the Polyomaviridae and Papillomaviridae families of DNA tumor viruses.

Authors:  Anuradha Kumar; Woo S Joo; Gretchen Meinke; Stephanie Moine; Elena N Naumova; Peter A Bullock
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

Review 5.  BRCT domains: easy as one, two, three.

Authors:  Charles Chung Yun Leung; J N Mark Glover
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

6.  Early embryonic lethality due to targeted inactivation of DNA ligase III.

Authors:  Nahum Puebla-Osorio; Devin B Lacey; Frederick W Alt; Chengming Zhu
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

7.  Terminal deoxynucleotidyl transferases from elasmobranchs reveal structural conservation within vertebrates.

Authors:  Simona Bartl; Ann L Miracle; Lynn L Rumfelt; Thomas B Kepler; Evonne Mochon; Gary W Litman; Martin F Flajnik
Journal:  Immunogenetics       Date:  2003-10-25       Impact factor: 2.846

8.  Two DNA-binding and nick recognition modules in human DNA ligase III.

Authors:  Elizabeth Cotner-Gohara; In-Kwon Kim; Alan E Tomkinson; Tom Ellenberger
Journal:  J Biol Chem       Date:  2008-01-30       Impact factor: 5.157

9.  Solution structure of polymerase mu's BRCT Domain reveals an element essential for its role in nonhomologous end joining.

Authors:  Eugene F DeRose; Michael W Clarkson; Steven A Gilmore; Cristina J Galban; Ashutosh Tripathy; Jody M Havener; Geoffrey A Mueller; Dale A Ramsden; Robert E London; Andrew L Lee
Journal:  Biochemistry       Date:  2007-10-04       Impact factor: 3.162

10.  Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor.

Authors:  Dean J Derbyshire; Balaku P Basu; Louise C Serpell; Woo S Joo; Takayasu Date; Kuniyoshi Iwabuchi; Aidan J Doherty
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.